Medtronic (MDT)
Medtronic Statistics
Share Statistics
Medtronic has 1.28B shares outstanding. The number of shares has increased by 0.02% in one year.
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | 0.02% |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | 82.87% |
| Shares Floating | 1.28B |
| Failed to Deliver (FTD) Shares | 35.59K |
| FTD / Avg. Volume | 0.46% |
Short Selling Information
The latest short interest is 10.84M, so 0.84% of the outstanding shares have been sold short.
| Short Interest | 10.84M |
| Short % of Shares Out | 0.84% |
| Short % of Float | 0.85% |
| Short Ratio (days to cover) | 1.19 |
Valuation Ratios
The PE ratio is 28.8 and the forward PE ratio is 14.17. Medtronic's PEG ratio is -13.58.
| PE Ratio | 28.8 |
| Forward PE | 14.17 |
| PS Ratio | 3.27 |
| Forward PS | 2.6 |
| PB Ratio | 2.11 |
| P/FCF Ratio | 20.36 |
| PEG Ratio | -13.58 |
Enterprise Valuation
Medtronic has an Enterprise Value (EV) of 130.63B.
| EV / Sales | 4.04 |
| EV / EBITDA | 15.93 |
| EV / EBIT | 19.25 |
| EV / FCF | 25.12 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.52.
| Current Ratio | 2.03 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | 5.01 |
| Interest Coverage | 7.15 |
Financial Efficiency
Return on Equity is 7.32% and Return on Invested Capital is 4.9%.
| Return on Equity | 7.32% |
| Return on Assets | 4.09% |
| Return on Invested Capital | 4.9% |
| Revenue Per Employee | $340.67K |
| Profits Per Employee | $38.69K |
| Employee Count | 95,000 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 2.15 |
Taxes
| Income Tax | 1.13B |
| Effective Tax Rate | 23.42% |
Stock Price Statistics
The stock price has increased by 4.28% in the last 52 weeks. The beta is 0.81, so Medtronic's price volatility has been higher than the market average.
| Beta | 0.81 |
| 52-Week Price Change | 4.28% |
| 50-Day Moving Average | 89.31 |
| 200-Day Moving Average | 86.56 |
| Relative Strength Index (RSI) | 38.2 |
| Average Volume (20 Days) | 7.76M |
Income Statement
In the last 12 months, Medtronic had revenue of 32.36B and earned 3.68B in profits. Earnings per share was 2.77.
| Revenue | 32.36B |
| Gross Profit | 21.15B |
| Operating Income | 5.14B |
| Net Income | 3.68B |
| EBITDA | 8.2B |
| EBIT | 5.56B |
| Earnings Per Share (EPS) | 2.77 |
Balance Sheet
The company has 1.28B in cash and 26.05B in debt, giving a net cash position of -24.76B.
| Cash & Cash Equivalents | 1.28B |
| Total Debt | 26.05B |
| Net Cash | -24.76B |
| Retained Earnings | 30.4B |
| Total Assets | 89.97B |
| Working Capital | 10.67B |
Cash Flow
In the last 12 months, operating cash flow was 6.79B and capital expenditures -1.59B, giving a free cash flow of 5.2B.
| Operating Cash Flow | 6.79B |
| Capital Expenditures | -1.59B |
| Free Cash Flow | 5.2B |
| FCF Per Share | 3.92 |
Margins
Gross margin is 65.34%, with operating and profit margins of 15.89% and 11.36%.
| Gross Margin | 65.34% |
| Operating Margin | 15.89% |
| Pretax Margin | 14.95% |
| Profit Margin | 11.36% |
| EBITDA Margin | 25.35% |
| EBIT Margin | 15.89% |
| FCF Margin | 16.07% |
Dividends & Yields
MDT pays an annual dividend of $2.8, which amounts to a dividend yield of 3.2%.
| Dividend Per Share | $2.80 |
| Dividend Yield | 3.2% |
| Dividend Growth (YoY) | 1.45% |
| Payout Ratio | 85.37% |
| Earnings Yield | 3.47% |
| FCF Yield | 4.91% |
Analyst Forecast
The average price target for MDT is $95, which is 15% higher than the current price. The consensus rating is "Hold".
| Price Target | $95 |
| Price Target Difference | 15% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
Stock Splits
The last stock split was on Sep 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.83 |
| Piotroski F-Score | 8 |